ArticleNPJ breast cancer2026

Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE.

Tatsunori Shimoi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.